Independent Advisor Alliance acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the fourth quarter ...

We think ResMed is a good business, but is it a buy today? Read our full report here, it’s free. Founded in 1989, Masimo Corporation (NASDAQ:MASI) develops and manufactures medical devices ...

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...

Van ECK Associates Corp’s holdings in ResMed were worth $9,440,000 at the end of the most recent quarter. Several other large investors have also added to or reduced their stakes in the business.

Learn More ResMed Inc (ASX: RMD) shares are in the red so far in 2025. After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.

These alliances fast-track AI integration across imaging, diagnostics and device automation. Resmed: It is actively progressing in the field of utilizing digital health technology to convert big ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2025 were $2.43, up 29.2% year over year. The metric beat the Zacks Consensus Estimate by 5.6%. The adjustments ...